ESMO Breast Cancer 2019: Abstracts

Abstract submission for ESMO Breast Cancer 2019 will open soon

Abstract submission deadlines

Deadline Date and time
Abstracts
Trial in Progress
Intent to submit LBA
30 January 2019, 12:00 CEST (Central European Summer Time)
Late breaking abstracts Final submission deadline* 03 April 2019, 12:00 CEST (Central European Summer Time)

*A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline (30 January 2019).

Final versions must be submitted by 03 April 2019, 12:00 CEST (Central European Summer Time).

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings with implications for clinical practice or understanding of disease processes. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to Breast 2019.

Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 30 January 2019 will be considered for late-breaking status.

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to Breast 2019.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design

Notes:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of 30 January 2019.
  • Abstracts including results or preliminary data will be rejected.
  • Authors of ‘encore’ TiP abstract submissions must supply information regarding the original presentation, indicating the name of the meeting and publication number. The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).
  • Trial in Progress abstracts will be accepted for Poster outcome only.

Outcome notifications

Outcome notifications are expected to be made available to first authors by March 2019.

Publication schedule of accepted abstracts

  • Abstracts accepted for presentation during ESMO Breast 2019 (Proffered Paper, Mini oral and Poster) and for publication in the ESMO Breast 2019 Abstract Book, will be published online on the ESMO Breast 2019 website on 1 May 2019. 
  • Late-breaking abstracts (LBA) accepted for presentation during ESMO Breast 2019 will be made public on the day of presentation during the official ESMO Breast 2019 Congress Programme. 
  • Abstracts and LBAs selected for the official ESMO Breast 2019 Press Programme will be available 10 days before the Congress.
Deadline Date and time
Abstracts accepted as:
Proffered Paper (suffix ‘O’)
Mini oral (suffix ‘O’)
Poster (suffix ‘P’)
1 May 2019, 12:00 Central European Summer Time (CEST)
Late-breaking abstracts (prefix ‘LBA’) On the day of presentation during the official ESMO Breast 2019 Congress programme
Abstracts and LBAs selected for the official ESMO
Press Programme (additional suffix ‘PR’)
The publication schedule will be available 10 days before the Congress

Presentation of accepted abstracts

The Breast 2019 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper (oral presentation) – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini oral – Short presentation by the authors with comment and interactive audience discussion led by an invited expert.
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

Publications

All accepted abstracts will be published as a supplement to the official ESMO journal Annals of Oncology.

Travel grants

Travel grants to the Congress will be available. Selection of travel grant recipients will be made by the Scientific Committee on a competitive basis from among the accepted abstracts submitted by candidates aged 40 years or younger. In addition to travel subsidies and accommodation, travel grant recipients will receive free registration to the Congress.

To apply for a travel grant, the following documents must be received by the ESMO Registration Service Unit before 30 January 2019.

  1. A letter of introduction by the applicant indicating the following general information:
    • How relevant are the topics presented during this Congress to your current practice and research?
    • Have you attended any event on a similar topic in the last 3 years?
    • How do you believe your attendance at this Congress will help you improve your knowledge in the field and your professional development?
    • How do you consider that the findings published in your abstract make a relevant contribution to the topics presented during this Congress?
    • Have you recently been awarded an ESMO travel grant? If yes, for which event?
  2. A copy of the submitted abstract (the applicant must be the first author and presenter)
  3. A readable photocopy of either identity card or passport
  4. A short curriculum vitae (maximum 2 pages)

Documentation must be sent by e-mail. ESMO will provide the recipients with a subsidised travel ticket, subsidised accommodation and Congress registration. Travel grant recipients must submit a report detailing the benefits of participating in the Congress by 30 January 2019.